Study | Reason for Exclusion |
Abdollahi, et al. BMJ. 2019;9:e026337, doi:10.1136/ bmjopen-2018-026337 |
It is a protocol |
Asghari, et al. Adv Phar Bull. 2018, 8(2), 307–317, doi:10.15171/apb.2018.036 | They do not evaluate glycemic parameters |
Bo, et al. Acta Diabetol. 2018;55:331–3402018, doi:10.1007/s00592-017-1097-4 | They do not report pre- and post-treatment means of glycemic parameters |
Brenjian, et al. Am J Reprod Immunol. 2020;83:e13186, doi:10.1111/aji.13186 | They do not evaluate glycemic parameters |
Cao, et al. Exp Ther Med. 2018; 15: 576–584, doi:10.3892/etm.2017.5400 | They do not evaluate glycemic parameters |
Crandall, et al. J Gerontol A Biol Sci Med Sci. 2012;67:1307–1312, doi:10.1093/gerona/glr235 | It is a pilot study |
Foroghi, et al. IJEM. 2018;20:169-176. | Language other than English |
Gospin, et al. J Investig Med 2016;64:800–825, doi:1 0.1136/jim-2016-000080.35 | Only abstract available |
Huhn, et al. 2018. NeuroImage Doi:10.1016/j.neuroimage.2018.03.023 | They use a combination of resveratrol with quercetin |
Kjaer, et al. The Prostate. 2015;75:1255–1263, doi:10.1002/pros.23006 | They do not evaluate glycemic parameters |
Knop, et al. Diabet Med. 2013;61:1886 Doi:10.1111/dme.12231 | They do not evaluate glycemic parameters |
Köbe, et al. Front. Neurosci. 2017. 11:105. Doi:10.3389/fnins.2017.00105 |
They use a combination of resveratrol with quercetin |
Konings, et al. Int J Obes. 2014;38:470–473. Doi:10.1038/ijo.2013.155 |
They do not evaluate glycemic parameters |
Korsholm, et al. Int. J. Mol. Sci. 2017, 18, 554; doi:10.3390/ijms18030554 | They do not evaluate glycemic parameters |
Maginley, et al. J Investig Med. 2019;67:793, doi:10.1136/jim-2019-001036.20 | Only abstract available |
Mahmood, et al. J. Pharm Sci Res. 2018;10(5):999–1005. | They do not evaluate glycemic parameters |
Milton-Laskibar, et al. IUBMB. 2016, doi:10.1002/biof.1347 | Study carried out on animals |
Most et al. Am J Clin Nutr 2016;104:215–27, doi:10.3945/ajcn.115.122937 | They use a combination of resveratrol with epigallocatechin |
Ornstrup, et al. J Clin Endocrinol Metab. 2014;99:4720–4729, doi:10.1210/jc.2014-2799 | They do not evaluate glycemic parameters |
Pankaj, et al. Biochem Bioph Res Co. 2015. 10.1016/j.bbrc.2015.10.126 | Study carried out on animals |
Poulsen, et al. Diabetes Obes Metab. 2018;20:2504–2509, doi:10.1111/dom.13409 | They do not report pre- and post-treatment means of glycemic parameters |
Theodotou, et al. Exp Ther Med. 2018; 18: 559–565, doi:10.3892/etm.2019.7607 | The comparison group is not a placebo |
Van der Made, et al. Nutrients. 2017;9,596, doi:10.3390/nu9060596 | They do not evaluate glycemic parameters |
Vatavuk-Serrati, et al. Rev Soc Cardiol Estado de São Paulo-Supl-2019;29(1):88–93 | Language other than English |
Voduc, et al. Appl. Physiol. Nutr. Metab. 2014. 39:1183–1188. Doi.org/10.1139/apnm-2013-0547 | It is a pilot study |
Walker, et al. J Clin Transl Res. 2019;4:122–135. Doi:10.18053/jctres.04.201802.004 |
It is a pilot study |
Wicklow, et al. Biochem Cell Biol. 2015; 93: 1–9, doi:/10.1139/bcb-2014-01362015 | It is a protocol |
Witte, et al. J Neurosci. 2014. 4(23):7862–7870, doi:10.1523/JNEURISCI.0385-14.2014 | They use a combination of resveratrol with quercetin |
Wong, et al. Nutr Metabol Cardiovasc Dis. 2016, doi:10.1016/j.numecd.2016.03.003 | They use a single dose of RV |
Wong, et al. Nutrients. 2016, 8, 425, doi:10.3390/nu8070425 | They use a single dose of RV |